Antibody · 전립선암

9개 · ADC 890 · Antibody 4097 · CGT 2985 · 다음 갱신 D-6 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved9 programs
AntibodyLimited DatastaleMerck Sharp & Dohme LLCPhase 2

Androgen receptor inhibitor (Androgen receptor inhibitor)

Prostate Cancer · Prostate Cancer

#ProstateCancer#Antibody#Phase2#Popular#monoclonal-antibody+2
Trials 54Status Recruiting
AntibodyLimited Datastale3D Medicines (Sichuan) Co., Ltd.Phase 2

Envafolimab (Envafolimab)

Prostate Cancer; CDK12 Gene Mutation · Prostate Cancer

#ProstateCancer#Antibody#Phase2#Popular#monoclonal-antibody+2
Trials 52Status Recruiting
AntibodyLimited DatastaleRegeneronPhase 2

Cemiplimab REGN2810 (Cemiplimab REGN2810)

Plasma Cell Myeloma · Prostate Cancer

#ProstateCancer#Antibody#Phase2#Popular#monoclonal-antibody+3
Trials 51Status Active
AntibodyLimited DatastaleXencor, Inc.Phase 2

Vudalimab (Vudalimab)

Ovarian Cancer; Clear Cell Carcinoma · Castration-Sensitive Prostate Carcinoma

#Castration-SensitiveProstateCarc#Antibody#Phase2#monoclonal-antibody#OvarianCancer+2
Trials 5Status Discontinued
AntibodyLimited DatastaleAmgenPhase 1

acapatamab (acapatamab)

Metastatic Castration-resistant Prostate Cancer; Prostate Cancer · Metastatic Castration-resistant Prostate

#MetastaticCastration-resistantPr#Antibody#Phase1#monoclonal-antibody#ProstateCancer+1
Trials 2Status Discontinued
AntibodyLimited DatastaleBioXcel Therapeutics IncPhase 2

pembrolizumab (Keytruda, BXCL701 plus Pembrolizumab)

Prostate Cancer; Neuroendocrine Tumors · Prostate Cancer

#ProstateCancer#Antibody#Phase2#monoclonal-antibody#NeuroendocrineTumors+1
Trials 1Status Active
AntibodyLimited DatastaleCorvus Pharmaceuticals, Inc.Phase 1

atezolizumab (Tecentriq, Ciforadenant + atezolizumab)

Renal Cell Cancer; Metastatic Castration Resistant Prostate Cancer · Renal Cell Cancer

#RenalCellCancer#Antibody#Phase1#monoclonal-antibody#MetastaticCastrationResistantPro+1
Trials 1Status Active
AntibodyLimited DatastaleRegeneronPhase 2

REGN15505+Cemiplimab (REGN15505+Cemiplimab)

Metastatic Castration-Resistant Prostate Cancer (mCRPC); Clear Cell Renal Cell Carcinoma (ccRCC) · Metastatic Castration-Resistant Prostate

#MetastaticCastration-ResistantPr#Antibody#Phase2#monoclonal-antibody#ClearCellRenalCellCarcinomaccRCC+1
Trials 1Status Recruiting
AntibodyLimited DatastaleInstitut Cancerologie de l'OuestPhase 2

durvalumab (Imfinzi, SBRT + Durvalumab)

Node; Prostate; Bone Metastases · Node; Prostate

#NodeProstate#Antibody#Phase2#monoclonal-antibody#Node+3
Trials 1Status Recruiting